LAD1 and neoplasm: The Ladinin 1 (LAD1) gene was identified recently by our group as a new candidate methylation marker in RCC showing univariate association with adverse clinicopathological parameters such as tumor grade, lymph node metastasis, status of distinct metastasis and advanced disease (unpublished data).